Dr. Saqib Jalil is a qualified pharmacist and researcher, holding a Ph.D. in Pharmaceutical Chemistry from COMSATS University Islamabad, Abbottabad Campus. With a foundational degree in Pharmacy and advanced postgraduate training (M.Phil. and Ph.D.) in Pharmaceutical Chemistry, Dr. Jalil has developed a strong academic and research profile focused on drug discovery, medicinal chemistry, and the design of multi-target therapeutic agents.
His doctoral research involved the synthesis and bio-evaluation of nitrogen-containing heterocyclic compounds, particularly targeting enzymes such as monoamine oxidase and β-amyloid aggregation inhibitors — with the aim of contributing to the treatment of neurodegenerative disorders, especially Alzheimer’s disease. Throughout his academic journey, he has gained substantial experience in organic synthesis, compound characterization, and in-vitro enzyme assays.
Dr. Jalil has co-authored several research articles published in reputed peer-reviewed journals and has presented his work at national and international scientific forums. He is dedicated to continuous learning and is passionate about translating laboratory-based research into clinically and industrially relevant applications.
With a strong command over scientific communication, time management, and collaborative research, Dr. Saqib Jalil aspires to contribute to academic, clinical, or industrial settings through impactful research and innovation in pharmaceutical sciences.
Dr. Saqib Jalil is a qualified pharmacist and researcher, holding a Ph.D. in Pharmaceutical Chemistry from COMSATS University Islamabad, Abbottabad Campus. With a foundational degree in Pharmacy and advanced postgraduate training (M.Phil. and Ph.D.) in Pharmaceutical Chemistry, Dr. Jalil has developed a strong academic and research profile focused on drug discovery, medicinal chemistry, and the design of multi-target therapeutic agents.
His doctoral research involved the synthesis and bio-evaluation of nitrogen-containing heterocyclic compounds, particularly targeting enzymes such as monoamine oxidase and β-amyloid aggregation inhibitors — with the aim of contributing to the treatment of neurodegenerative disorders, especially Alzheimer’s disease. Throughout his academic journey, he has gained substantial experience in organic synthesis, compound characterization, and in-vitro enzyme assays.
Dr. Jalil has co-authored several research articles published in reputed peer-reviewed journals and has presented his work at national and international scientific forums. He is dedicated to continuous learning and is passionate about translating laboratory-based research into clinically and industrially relevant applications.
With a strong command over scientific communication, time management, and collaborative research, Dr. Saqib Jalil aspires to contribute to academic, clinical, or industrial settings through impactful research and innovation in pharmaceutical sciences.